Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-3370.18%EBITDA Margin
VS
Market
Sector
Industry
History
$ 3.7Close
$ 0.88 - $ 4.74 52-Week Range
Ticker Information
Ticker
PYXSCompany Name
PYXIS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPYXIS ONCOLOGY INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PYXS - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -95.04M | -3370.18% | $ 2.82M |
| 3/31/2025 | $ -94.25M | 0% | $ 0 |
| 12/31/2024 | $ -75.81M | -469.55% | $ 16.15M |
| 9/30/2024 | $ -53.53M | -331.56% | $ 16.15M |
| 6/30/2024 | $ -55.61M | -344.44% | $ 16.15M |
| 3/31/2024 | $ -54.27M | -336.12% | $ 16.15M |
| 12/31/2023 | $ -71.2M | 0% | $ 0 |
| 9/30/2023 | $ -92.12M | 0% | $ 0 |
| 6/30/2023 | $ -96.92M | 0% | $ 0 |
| 3/31/2023 | $ -106.8M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- PYXIS ONCOLOGY INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
- Over the past 5 years, PYXIS ONCOLOGY INC's average EBITDA % has been -970.37%.
- The median EBITDA % for PYXIS ONCOLOGY INC during this period was -344.44%
- PYXIS ONCOLOGY INC reached its highest EBITDA % over the past 5 years at -331.56%.
- The lowest EBITDA % recorded by PYXIS ONCOLOGY INC in the same timeframe -3370.18%
PYXIS ONCOLOGY INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for PYXIS ONCOLOGY INC is calculated as follows: EBITDA [ $ -12.41M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ] PYXS - EBITDA Margin, Last 5 years
-3370.18%
Minimum
Jun 30, 2025
-331.56%
Maximum
Sep 30, 2024
-970.37%
Average
-344.44%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |